IP Library Granted Patent US 11,136,355
Granted Patent B2
US 11,136,355 · App. 16/886,387 · Granted Oct 5, 2021

Non-naturally occurring porcine reproductive and respiratory syndrome virus (PRRSV) and methods of using

Inventors: Hiep Lai Xuan Vu (Lincoln, NE); Fernando Osorio (Lincoln, NE); William W. Laegreid (Laramie, WY); Asit K. Pattnaik (Lincoln, NE); Fangrui Ma (Lincoln, NE)
Assignee: NUtech Ventures
C07K14/005A61K39/12C12N7/00A61K2039/552C12N2770/10021C12N2770/10022C12N2770/10034
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,136,355
App. No.
16/886,387
Granted
Oct 5, 2021
Kind
B2
Abstract

A non-naturally occurring porcine reproductive and respiratory syndrome virus (PRRSV) is provided herein, and methods of making and using the non-naturally occurring PRRSV also are provided.

Claims (12)

1. A porcine reproductive and respiratory syndrome virus (PRRSV)-CON polypeptide consisting of a sequence selected from the group consisting of SEQ ID NOs: 29, 31, 33, and 35.

2. The polypeptide of claim 1 , wherein the polypeptide is encoded by a nucleic acid, respectively, having a sequence selected from the group consisting of SEQ ID NOs: 28, 30, 32, and 34.

3. A virus particle comprising the PRRSV-CON polypeptide of claim 1 .

4. A composition comprising the virus particle of claim 3 and a pharmaceutically acceptable carrier.

5. A composition comprising the polypeptide of claim 1 and a pharmaceutically acceptable carrier.

6. The composition of claim 5 , further comprising an adjuvant.

7. A method for eliciting an immune response to PRRSV in a porcine, comprising administering, to a porcine:

an effective amount of the polypeptide of claim 1 .

8. The method of claim 7 , wherein the administration is selected from the group consisting of intramuscularly, intraperitoneally, and orally.

9. A method for treating or preventing PRRS in a porcine, comprising administering, to a porcine:

an effective amount of the polypeptide of claim 1 .

10. The method of claim 9 , wherein the administration is selected from the group consisting of intramuscularly, intraperitoneally, and orally.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE SHOULD BE "HIEP LAI XUAN VU" (MISSING "XUAN") PREVIOUSLY RECORDED ON REEL 052842 FRAME 0198. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 17, 2021
From: VU, HIEP LAI XUAN; OSORIO, FERNANDO; PATTNAIK, ASIT K.; MA, FANGRUI
To: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Reel/Frame 056613/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2020
From: VU, HIEP LAI; OSORIO, FERNANDO; PATTNAIK, ASIT K.; MA, FANGRUI
To: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Reel/Frame 052842/0198 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2020
From: LAEGREID, WILLIAM W.
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 052842/0362 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2020
From: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
To: NUTECH VENTURES
Reel/Frame 052842/0445 →
Continuity (4)
Continuation 16054327 · Aug 3, 2018
Continuation 15127931
Provisional Application 61968465 · Mar 21, 2014
Related Publication 20200331970A1 · Oct 22, 2020